Showing results (331-340 of 528) with videos related to

Sort By:
Pageof 53
Nature Biotechnology|July 15, 2026
High-fidelity fast fluorescence lifetime imaging by event-based denoisingYiliang Zhou, Yihong Xiao, Jing Zhou, et al.
Journal of Colloid and Interface Science|June 21, 2017
Surface enhanced Raman scattering properties of dynamically tunable nanogaps between Au nanoparticles self-assembled on hydrogel microspheres controlled by pHHuilin Li, Dandan Men, Yiqiang Sun, et al.
Computational and Structural Biotechnology Journal|August 21, 2023
Molecular epidemiology and genomic characterization of a plasmid-mediated <i>mcr-10</i> and <i>bla</i><sub>NDM-1</sub> co-harboring multidrug-resistant <i>Enterobacter asburiae</i>Xinyang Li, Tian Jiang, Chenghao Wu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 19, 2023
Bionic Structural Coloration of Textiles Using the Synthetically Prepared Liquid Photonic CrystalsXinyang Li, Xiaohui Wang, Yanan Wang, et al.
Frontiers in Cell and Developmental Biology|January 3, 2022
The Synergistic Effects of SHR6390 Combined With Pyrotinib on HER2+/HR+ Breast CancerYukun Wang, Xiang Yuan, Jing Li, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 3, 2022
Clinical features and risk factors of catheter removal among 1062 episodes of peritoneal dialysis-associated peritonitis: A multicenter 7-year studyShichen Liu, Liming Yang, Xueyan Zhu, et al.
Endocrine|December 6, 2022
Optimal method for detecting cervical lymph node metastasis from papillary thyroid cancerJing Xiao, Shuyu Meng, Mingbo Zhang, et al.
Frontiers in Oncology|May 20, 2022
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid CarcinomaJiachun Sun, Zhiyi Jiang, Tanyou Shan, et al.
Pharmaceutics|April 28, 2023
Clinical Translation of Long-Acting Drug Delivery Systems for Posterior Capsule Opacification ProphylaxisXinyang Li, Chen Liang, Yexuan Guo, et al.
Frontiers in Oncology|March 7, 2022
Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer CellsXinyang Li, Xiang Yuan, Ziming Wang, et al.
Pageof 53